Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease-Reference-Cited by-同舟云学术

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease

Published:2016 Issue: Volume: Page:249-269
ISSN:0171-2004
Container-title:Heart Failure
language:
Short-container-title:

Author:

Kim Grace E.,Kass David A.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/164_2016_82

Reference115 articles.

1. Adamo CM et al (2010) Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 107:19079–19083

2. Ahmad F et al (2015) Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2. J Biol Chem 290:6763–6776

3. Albert CL, Sleeper M, Sweeney HL (2012) Abstract 9504: phosphodiesterase modulation of cardiomyopathy in Murine and Canine models of muscular dystrophy treated with sildenafil and tadalafil. Circulation 126:A9504

4. Andersen RO et al (2012) Sgt1 acts via an LKB1/AMPK pathway to establish cortical polarity in larval neuroblasts. Dev Biol 363:258–265

5. Beca S et al (2013) Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart. Circ Res 112:289–297

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the selective mechanism of PDE2/9a inhibitors from silico aspects;Journal of Biomolecular Structure and Dynamics;2024-03-25

2. Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics;European Journal of Medicinal Chemistry;2024-01

3. Exploring the Multifaceted Potential of Sildenafil in Medicine;Medicina;2023-12-17

4. Pharmacological Evidence That Dictyostelium Differentiation-Inducing Factor 1 Promotes Glucose Uptake Partly via an Increase in Intracellular cAMP Content in Mouse 3T3-L1 Cells;Molecules;2023-12-04

5. An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential;European Journal of Medicinal Chemistry;2023-11